The abnormal expression of ncRNAs mainly regulates cell proliferation and apoptosis through PI3K/AKT, MAPK and Wnt/β-catenin pathways, which eventually alters the sensitivity of lung cancer cells to chemotherapeutic drugs. The gene discussed is AKT1; the disease is lung cancer.